The efficacy and safety of irsogladine maleate in nonsteroidal anti-inflammatory drug or aspirin-induced peptic ulcer and gastritis

The Korean Journal of Internal Medicine
Ki-Nam ShimJi Won Kim

Abstract

Irsogladine maleate, an enhancer of gastric mucosal protective factors, has demonstrated its efficacy for various gastric mucosal injuries. The aim of this study was to evaluate the efficacy and safety of irsogladine for prevention of nonsteroidal anti-inflammatory drugs (NSAIDs) or aspirin-induced peptic ulcer and gastritis. In this multicenter, randomized, double-blind, exploratory clinical trial, 100 patients over 50 years of age who needed continuous NSAIDs or aspirin for more than 8 weeks were randomly assigned to either test group (irsogladine maleate 2 mg, twice daily, 39 patients for full analysis) or placebo group (37 patients for full analysis). Primary outcomes were incidence of peptic ulcer and ratio of modified Lanza score (MLS) 2 to 4. Secondary outcome was the number of acute erosions confirmed by endoscopy at 8 weeks. Adverse effects were also compared. There were no significant differences in gastric protective effects between test and placebo groups. However, two cases of peptic ulcer in the placebo group but none in the test group were observed. These two cases of peptic ulcer were Helicobacter pylori-negative. In addition, H. pylori-negative group showed significant changes in MLS score (p = 0.0247) and edem...Continue Reading

Associated Clinical Trials

References

May 1, 1991·Journal of Gastroenterology and Hepatology·G N Tytgat
May 15, 1994·International Journal of Radiation Oncology, Biology, Physics·C L HilburgerK C Agrawal
Jan 16, 2003·Seminars in Arthritis and Rheumatism·Loren Laine
Feb 17, 2005·Digestive Diseases and Sciences·Yaron NivAlex Vilkin
Oct 18, 2005·Alimentary Pharmacology & Therapeutics·N D YeomansC J Hawkey
Sep 22, 2006·BMC Medicine·Sonia Hernández-Díaz, Luis A García Rodríguez
Feb 18, 2009·Alimentary Pharmacology & Therapeutics·J J Y SungH B El-Serag
Aug 19, 2009·Journal of Gastroenterology and Hepatology·Kee Don ChoiIn Sung Song
Sep 30, 2009·The American Journal of Medicine·Tauseef AliWilliam M Tierney
Nov 26, 2009·The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi·Dae Young CheungUNKNOWN Korean Association of Gastroenterology
Aug 21, 2010·American Journal of Physiology. Gastrointestinal and Liver Physiology·Jung Mook KangIn Sung Song
Oct 22, 2010·The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi·Jin Joo KimIn Sung Song
Apr 8, 2011·Gut·Joseph J Y SungUNKNOWN Asia-Pacific Working Group
Mar 24, 2012·European Journal of Gastroenterology & Hepatology·SeungJin BaeKi-Nam Shim
Apr 12, 2012·Gut·Peter MalfertheinerUNKNOWN European Helicobacter Study Group
May 9, 2012·Journal of Gastroenterology·Adam J Smolka, Steffen Backert
Dec 7, 2013·Arthritis Research & Therapy·Carlos SostresAngel Lanas

❮ Previous
Next ❯

Methods Mentioned

BETA
contraception
MDA
biopsy
ELISA

Software Mentioned

SAS

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

Atrophic Gastritis

Atrophic Gastritis is a process where gastric glandular cells are lost and replaced with firbous tissues, as a result of chronic inflammation. Learn more about Atrophic Gastritis here.